Rosalind Advisors, Inc. Hedge Fund

Location: Toronto, Ontario, Canada

CIK: 0001622627 · Show all filings

Period: Q1 2026 (← Previous) (Next →)

Filing Date: May 14, 2026

Total Value: $249M (100.0% shares, 0.0% debt)

Holdings (38)

DCTH DELCATH SYSTEMS, INC. 12.3%
Value $30.63M Shares 3,300,389 Est. Cost $6.89 Unrealized +45.0%
XERS XERIS BIOPHARMA HOLDINGS INC 7.5%
Value $18.74M Shares 3,231,700 Est. Cost $4.30 Unrealized +67.6%
FENC FENNEC PHARMACEUTICALS INC 7.2%
Value $17.89M Shares 2,908,201 Est. Cost $6.41 Unrealized +24.1%
SVRA SAVARA INC 7.0%
Value $17.49M Shares 3,203,721 Est. Cost $3.31 Unrealized +72.1%
PCVX VAXCYTE INC 6.8%
Value $16.85M Shares 290,000 Est. Cost $52.77 Unrealized 0.0%
EYPT EYEPOINT PHARMACEUTICALS INC 5.4%
Value $13.36M Shares 1,036,737 Est. Cost $12.85 Unrealized +18.4%
XFOR X4 PHARMACEUTICALS INC 5.3%
Value $13.28M Shares 3,214,766 Est. Cost $3.13 Unrealized +16.3%
VOR VOR BIOPHARMA INC 5.0%
Value $12.49M Shares 700,000 Est. Cost $13.98 Unrealized 0.0%
MDWD MEDIWOUND LTD 4.8%
Value $12.07M Shares 749,054 Est. Cost $14.40 Unrealized +23.2%
VSTM VERASTEM INC 4.6%
Value $11.33M Shares 2,138,475 Est. Cost $5.55 Unrealized +16.6%
CLDX CELLDEX THERAPEUTICS INC 4.2%
Value $10.47M Shares 330,000 Est. Cost $25.41 Unrealized 0.0%
BCRX BIOCRYST PHARMACEUTICALS INC 3.5%
Value $8.788M Shares 923,057 Est. Cost $7.00 Unrealized 0.0%
HELP CYBIN INC 3.0%
Value $7.353M Shares 1,531,814 Est. Cost $8.53 Unrealized -16.7%
CGON CG ONCOLOGY INC 2.7%
Value $6.768M Shares 100,000 Est. Cost $25.87 Unrealized +102.6%
NSPR INSPIREMD INC 2.6%
Value $6.366M Shares 3,905,743 Est. Cost $2.46 Unrealized -30.6%
AVIR ATEA PHARMACEUTICALS INC 2.5%
Value $6.305M Shares 1,171,855 Est. Cost $3.98 Unrealized 0.0%
PROF PROFOUND MEDICAL CORP 2.2%
Value $5.366M Shares 828,118 Est. Cost $8.06 Unrealized -7.8%
VRDN VIRIDIAN THERAPEUTICS INC 2.0%
Value $4.898M Shares 250,401 Est. Cost $16.51 Unrealized +86.8%
REPLIMUNE GROUP INC 1.1%
Value $2.747M Shares 1,275,600 Est. Cost Unrealized
PYPD POLYPID LTD 1.1%
Value $2.619M Shares 597,926 Est. Cost $4.49 Unrealized +0.6%
MYO MYOMO INC 1.0%
Value $2.599M Shares 3,847,272 Est. Cost $3.08 Unrealized -71.6%
TLPH TALPHERA INC 1.0%
Value $2.505M Shares 3,353,916 Est. Cost $0.60 Unrealized +59.3%
OVID OVID THERAPEUTICS INC 1.0%
Value $2.46M Shares 1,107,994 Est. Cost $1.60 Unrealized 0.0%
DFTX DEFINIUM THERAPEUTICS INC 0.9%
Value $2.362M Shares 125,000 Est. Cost $16.29 Unrealized 0.0%
OKUR ONKURE THERAPEUTICS INC 0.7%
Value $1.837M Shares 443,763 Est. Cost $2.99 Unrealized -8.8%
LPCN LIPOCINE INC 0.7%
Value $1.771M Shares 221,616 Est. Cost $9.20 Unrealized 0.0%
NRXS NEURAXIS INC 0.7%
Value $1.694M Shares 286,138 Est. Cost $2.99 Unrealized +58.6%
AVTX AVALO THERAPEUTICS INC 0.4%
Value $1.12M Shares 75,000 Est. Cost $15.50 Unrealized 0.0%
ANNX ANNEXON INC 0.4%
Value $1.108M Shares 200,000 Est. Cost $5.75 Unrealized 0.0%
INVESCO QQQ TR 0.4%
Value $1.053M Shares 250,000 Est. Cost Unrealized
AQST AQUESTIVE THERAPEUTICS INC 0.4%
Value $1.038M Shares 250,000 Est. Cost $4.02 Unrealized 0.0%
SPDR S&P 500 ETF TR 0.4%
Value $959K Shares 125,000 Est. Cost Unrealized
BFRI BIOFRONTERA INC 0.4%
Value $942K Shares 1,163,962 Est. Cost $1.02 Unrealized -15.1%
KURA KURA ONCOLOGY INC 0.3%
Value $813K Shares 100,000 Est. Cost $7.79 Unrealized +10.5%
RGNT REGENTIS BIOMATERIALS LTD 0.3%
Value $768K Shares 251,510 Est. Cost $6.86 Unrealized -16.3%
VIRIDIAN THERAPEUTICS INC 0.0%
Value $52,720 Shares 263,600 Est. Cost Unrealized
ARRIVENT BIOPHARMA INC 0.0%
Value $0 Shares 108,900 Est. Cost Unrealized
UNIQURE NV 0.0%
Value $0 Shares 295,800 Est. Cost Unrealized